Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.

Magalhães, Nathalia Santos; Savino, Wilson; Silva, Patrícia Machado Rodrigues; Martins, Marco Aurélio; Carvalho, Vinicius Frias

Magalhães, Nathalia Santos; Savino, Wilson; Silva, Patrícia Machado Rodrigues; Martins, Marco Aurélio; Carvalho, Vinicius Frias.

Afiliación

Magalhães NS; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Savino W; Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Silva PMR; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Martins MA; Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Carvalho VF; Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.

Front Med (Lausanne) ; 8: 644751, 2021.

Article en En | MEDLINE | ID: mdl-34458281

Palabras clave

COVID19; SARS-CoV-2; aging; diabetes; gut microbiota; hypertension

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google